PortfoliosLab logoPortfoliosLab logo
SNY vs. AVY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SNY vs. AVY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sanofi (SNY) and Avery Dennison Corporation (AVY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SNY achieves a -3.62% return, which is significantly higher than AVY's -11.44% return. Over the past 10 years, SNY has underperformed AVY with an annualized return of 5.78%, while AVY has yielded a comparatively higher 9.69% annualized return.


SNY

1D
0.32%
1M
3.65%
YTD
-3.62%
6M
-4.06%
1Y
-5.97%
3Y*
0.21%
5Y*
0.40%
10Y*
5.78%

AVY

1D
0.31%
1M
2.60%
YTD
-11.44%
6M
-11.79%
1Y
-6.75%
3Y*
0.06%
5Y*
-4.53%
10Y*
9.69%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SNY vs. AVY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SNY
Sanofi
-3.62%4.93%1.09%6.55%0.57%7.00%0.39%20.47%6.06%9.96%
AVY
Avery Dennison Corporation
-11.44%-0.73%-5.95%13.66%-15.06%41.41%20.86%48.54%-20.28%66.75%

Correlation

The correlation between SNY and AVY is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.44

Correlation (3Y)
Calculated over the trailing 3-year period

0.33

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Jul 1, 2002

0.37

The correlation between SNY and AVY shifts across timeframes, from 0.27 (10 years) to 0.44 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

SNY:

$106.57B

AVY:

$12.26B

EPS

SNY:

€3.09

AVY:

$8.87

PE Ratio

SNY:

12.38

AVY:

17.95

PS Ratio

SNY:

1.98

AVY:

1.37

PB Ratio

SNY:

1.27

AVY:

5.33

Total Revenue (TTM)

SNY:

€47.35B

AVY:

$9.01B

Gross Profit (TTM)

SNY:

€34.18B

AVY:

$2.59B

EBITDA (TTM)

SNY:

€12.63B

AVY:

$1.24B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SNY vs. AVY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SNY
SNY Risk / Return Rank: 2626
Overall Rank
SNY Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
SNY Sortino Ratio Rank: 2626
Sortino Ratio Rank
SNY Omega Ratio Rank: 2626
Omega Ratio Rank
SNY Calmar Ratio Rank: 2626
Calmar Ratio Rank
SNY Martin Ratio Rank: 2424
Martin Ratio Rank

AVY
AVY Risk / Return Rank: 2525
Overall Rank
AVY Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
AVY Sortino Ratio Rank: 2222
Sortino Ratio Rank
AVY Omega Ratio Rank: 2323
Omega Ratio Rank
AVY Calmar Ratio Rank: 2929
Calmar Ratio Rank
AVY Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SNY vs. AVY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Avery Dennison Corporation (AVY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SNYAVYDifference
Sharpe ratioReturn per unit of total volatility

+0.07

Sortino ratioReturn per unit of downside risk

+0.20

Omega ratioGain probability vs. loss probability

0.97

0.95

+0.01

Calmar ratioReturn relative to maximum drawdown

-0.49

-0.43

-0.06

Martin ratioReturn relative to average drawdown

-0.96

-0.91

-0.05

SNY vs. AVY - Sharpe Ratio Comparison

The current SNY Sharpe Ratio is -0.32, which is comparable to the AVY Sharpe Ratio of -0.39. The chart below compares the historical Sharpe Ratios of SNY and AVY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SNY vs. AVY - Drawdown Comparison

The maximum SNY drawdown since its inception was -46.46%, smaller than the maximum AVY drawdown of -73.03%. Use the drawdown chart below to compare losses from any high point for SNY and AVY.


Loading charts...

Drawdown Indicators


SNYAVYDifference

Max Drawdown

Largest peak-to-trough decline

-46.46%

-73.03%

+26.57%

Max Drawdown (1Y)

Largest decline over 1 year

-16.70%

-21.62%

+4.92%

Max Drawdown (3Y)

Largest decline over 3 years

-23.37%

-30.56%

+7.19%

Max Drawdown (5Y)

Largest decline over 5 years

-33.52%

-31.80%

-1.72%

Max Drawdown (10Y)

Largest decline over 10 years

-33.52%

-43.52%

+10.00%

Current Drawdown

Current decline from peak

-17.91%

-27.73%

+9.82%

Average Drawdown

Average peak-to-trough decline

-12.20%

-16.79%

+4.59%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.63%

10.16%

-1.53%

Volatility

SNY vs. AVY - Volatility Comparison

Sanofi (SNY) has a higher volatility of 8.05% compared to Avery Dennison Corporation (AVY) at 7.39%. This indicates that SNY's price experiences larger fluctuations and is considered to be riskier than AVY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SNYAVYDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.05%

7.39%

+0.66%

Volatility (6M)

Calculated over the trailing 6-month period

15.99%

16.29%

-0.30%

Volatility (1Y)

Calculated over the trailing 1-year period

25.71%

23.82%

+1.89%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.82%

24.68%

+0.14%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.47%

27.06%

-3.59%

Dividends

SNY vs. AVY - Dividend Comparison

SNY's dividend yield for the trailing twelve months is around 5.47%, more than AVY's 2.40% yield.


PositionTTM20252024202320222021202020192018201720162015
AVY
Avery Dennison Corporation
2.40%2.03%1.84%1.57%1.62%1.23%1.52%1.73%2.24%1.53%2.28%2.33%
SNY
Sanofi
5.47%4.56%4.22%3.83%4.32%3.80%3.61%3.47%4.29%3.82%4.11%3.77%

Financials

SNY vs. AVY - Financials Comparison

This section allows you to compare key financial metrics between Sanofi and Avery Dennison Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B12.00B14.00B20222023202420252026
11.24B
2.30B
(SNY) Total Revenue
(AVY) Total Revenue
Please note, different currencies. SNY values in EUR, AVY values in USD

SNY vs. AVY - Profitability Comparison

The chart below illustrates the profitability comparison between Sanofi and Avery Dennison Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%20222023202420252026
72.1%
28.9%
Portfolio components
SNY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sanofi reported a gross profit of 8.11B and revenue of 11.24B. Therefore, the gross margin over that period was 72.1%.

AVY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Avery Dennison Corporation reported a gross profit of 664.80M and revenue of 2.30B. Therefore, the gross margin over that period was 28.9%.

SNY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sanofi reported an operating income of 2.27B and revenue of 11.24B, resulting in an operating margin of 20.2%.

AVY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Avery Dennison Corporation reported an operating income of 271.90M and revenue of 2.30B, resulting in an operating margin of 11.8%.

SNY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sanofi reported a net income of 1.61B and revenue of 11.24B, resulting in a net margin of 14.4%.

AVY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Avery Dennison Corporation reported a net income of 168.10M and revenue of 2.30B, resulting in a net margin of 7.3%.


Frequently Asked Questions


SNY and AVY have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SNY has higher volatility (8.05%) compared to AVY (7.39%). In terms of maximum drawdown, SNY dropped -46.46% vs AVY's -73.03%.

SNY currently has the higher Sharpe Ratio (-0.32 vs -0.39), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SNY and AVY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer